Breaking News
January 20, 2018 - Morning Break: Missing Maria Deaths; N.J. Doc Charged in Wife’s Murder; Viva Vaseline!
January 20, 2018 - No interventions proven to prevent late-life dementia
January 20, 2018 - Judge orders new Olympus trial over superbug death
January 20, 2018 - Don’t Rely on Just One Blood Pressure Test for Kids: Study
January 20, 2018 - Going Off the Deep End About Water
January 20, 2018 - Parental attention can reduce risk of drug abuse in adolescence
January 20, 2018 - Mast Uri System offers efficient and cost-friendly diagnostic solution
January 20, 2018 - International SOS, Chatham House sign partnership agreement to further advance Global Health Security Agenda
January 20, 2018 - Study offers way to predict onset of lung disease in children with cystic fibrosis
January 20, 2018 - C-Suite Must Lead in Ending Sexual Harassment
January 20, 2018 - Researchers find a way to ‘starve’ cancer
January 20, 2018 - Applied math can help predict genesis and evolution of different cancers
January 20, 2018 - UCLA researchers describe herpes virus structure associated with Kaposi’s sarcoma
January 20, 2018 - New study enrolls first patient to evaluate potential of WaveCrest LAAO System
January 20, 2018 - New review explores effects of exposing developing brains to general anesthesia
January 20, 2018 - GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
January 20, 2018 - Weight-Loss Surgery Approaches Offer Similar Results
January 20, 2018 - Free online access to millions of documents on chemical toxicity
January 20, 2018 - CE marked MAST Toxoreagent kit for detection of Toxoplasma antibodies
January 20, 2018 - DNA study sheds light on longstanding puzzle of cell division
January 20, 2018 - Montefiore provides specialized medical care to parents of adopted children
January 20, 2018 - Enzyme discovery provides new horizon of therapeutic opportunities across disease spectrum
January 20, 2018 - New smartphone app successfully enables remote monitoring of surgical wounds
January 20, 2018 - Liquid Biopsy Shows Promise for Colon Cancer
January 20, 2018 - Surgery death rates in Africa are twice global average: study
January 20, 2018 - New isothermal amplification kit using LAMP technology
January 20, 2018 - Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows
January 20, 2018 - Health Highlights: Jan. 17, 2018
January 20, 2018 - House Opioid Task Force has Big Plans for 2018
January 20, 2018 - Perfectionism among young people significantly increased since 1980s, study finds
January 20, 2018 - Evidensia Sweden orders Sectra cloud-based PACS for reviewing all medical images
January 20, 2018 - Researchers test new anti-malaria medication
January 20, 2018 - Small Joint Surgeries Drop among RA Patients
January 20, 2018 - Young people with shared residency have fewer mental problems
January 20, 2018 - Childhood physical activity may have far-reaching implications
January 20, 2018 - Overweight female kidney donors of childbearing age may have greater preeclampsia risk
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - CBT is cost-effective treatment in primary care setting, Kaiser Permanente study finds
January 20, 2018 - Scientists find how potential new eczema treatment could also alleviate asthma
January 20, 2018 - Older hospitalized patients less likely to be tested for influenza
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Study provides more evidence for link between increased cancer risk and advanced gum disease
January 19, 2018 - Study reveals key mechanism of how cancer metastasis happens
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - AMSBIO offers isogenic panels of neuronal iPSC derivatives
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
Fecal Occult Blood Test (FOBT): MedlinePlus Lab Test Information

Fecal Occult Blood Test (FOBT): MedlinePlus Lab Test Information

image_pdfDownload PDFimage_print

What is a Fecal Occult Blood Test?

A fecal occult blood test (FOBT) looks at a sample of your stool (feces) to check for blood. Occult blood means that you can’t see it with the naked eye. Blood in the stool means there is likely some kind of bleeding in the digestive tract. It may be caused by a variety of conditions, including:

Blood in the stool may also be a sign of colorectal cancer, a type of cancer that starts in the colon or rectum. Colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women. A fecal occult blood test is a screening test that may help find colorectal cancer early, when treatment is most effective.

Other names: FOBT, stool occult blood, occult blood test, Hemoccult test, guaiac smear test, gFOBT, immunochemical FOBT, iFOBT; FIT

What is it used for?

A fecal occult blood test is used as an early screening test for colorectal cancer. It may also be used to diagnose other conditions that cause bleeding in the digestive tract.

Why do I need a fecal occult blood test?

The National Cancer Institute recommends that people get regular screenings for colorectal cancer starting at age 50. The screening may be a fecal occult test, a colonoscopy, or another test. Talk with your health care provider about which test is right for you.

If you choose a fecal occult blood test, you need to get it every year. If you have a colonoscopy, you only need it every ten years. But it is a more invasive procedure. You may need screening more often if you have certain risk factors. These include:

What happens during a fecal occult blood test?

A fecal occult blood test is a noninvasive test that you can perform at home at your convenience. Your health care provider will give you a kit that includes instructions on how to do the test. There are two main types of fecal occult blood tests: the guaiac smear method (gFOBT) and the immunochemical method (iFOBT or FIT). Below are typical instructions for each test. Your instructions may vary slightly depending on the manufacturer of the test kit.

For a guaiac smear test (gFOBT), you will most likely need to:

  • Collect samples from three separate bowel movements.
  • For each sample, collect the stool and store in a clean container. Make sure the sample does not mix in with urine or water from the toilet.
  • Use the applicator from your test kit to smear some of the stool on the test card or slide, also included in your kit.
  • Label and seal all your samples as directed.
  • Mail the samples to your health care provider or lab.

For a fecal immunochemical test (FIT), you will most likely need to:

  • Collect samples from two or three bowel movements.
  • Collect the sample from the toilet using the special brush or other device that was included in your kit.
  • For each sample, use the brush or device to take the sample from the surface of the stool.
  • Brush the sample onto a test card.
  • Label and seal all your samples as directed.
  • Mail the samples to your health care provider or lab.

Be sure to follow all the instructions provided in your kit, and talk to your health care provider if you have any questions.

Will I need to do anything to prepare for the test?

Certain foods and drugs may affect the results of a guaiac smear method (gFOBT) test. Your health care provider may ask you to avoid the following:

  • Nonsteroidal, anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or aspirin for seven days prior to your test. If you take aspirin for heart problems, talk to your health care provider before stopping your medicine. Acetaminophen may be safe to use during this time, but check with your health care provider before taking it.
  • More than 250 mg of vitamin C daily from supplements, fruit juices, or fruit for seven days prior to your test. Vitamin C can affect the chemicals in the test and cause a negative result even if there is blood present.
  • Red meat, such as beef, lamb, and pork, for three days prior to the test. Traces of blood in these meats may cause a false-positive result.

There are no special preparations or dietary restrictions for a fecal immunochemical test (FIT).

Are there any risks to the test?

There is no known risk to having a fecal occult blood test.

What do the results mean?

If your results are positive for either type of fecal occult blood test, it means you likely have bleeding somewhere in your digestive tract. But it does not necessarily mean you have cancer. Other conditions that may produce a positive result on a fecal occult blood test include ulcers, hemorrhoids, polyps, and benign tumors. If your test results are positive for blood, your health care provider will likely recommend additional testing, such as a colonoscopy, to figure out the exact location and cause of your bleeding. If you have questions about your results, talk to your health care provider.

Is there anything else I need to know about a fecal occult blood test?

Regular colorectal cancer screenings, such as the fecal occult blood test, are an important tool in the fight against cancer. Studies show that screening tests can help find cancer early, and may reduce deaths from the disease.

Tagged with:

About author

Related Articles